C. Horreau

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

Chronic inflammation in the etiology of disease across the life span

Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis

Psoriasis

Psoriasis, psoriatic arthritis and risk of gout in US men and women

Psoriasis

Obesity in autoimmune diseases: Not a passive bystander

The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis

The JAK/STAT signaling pathway: from bench to clinic

Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry

Hidradenitis suppurativa

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases

Global epidemiology of gout: prevalence, incidence and risk factors

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Psoriasis Pathogenesis and Treatment

Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

Risk of cancer in psoriasis: a systematic review and meta‐analysis of epidemiological studies

Alcohol consumption and psoriasis: a systematic literature review

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review